Related to Pfizer to Study Liver Cancer in Korean Patients with Samsung Medical Center

• Pfizer Quashes Three More Phase III Cancer Trials
  
• FDA Stalls Approval of Amylin, Lilly, and Alkermes’ Type 2 Diabetes Therapy
  
• Cosmo Bio to Distribute Bio-Quant’s Discovery and Preclinical CRO Services in Japan
  
• Beijing Pioneer to Provide Olink’s Duolink Product Line in China
  
• Veritas to Supply International Stem Cell’s Products in Japan
  
• ICON and Tigermed Team Up to Facilitate Access to Chinese Patient Populations
  
• Charles River to Take Over Sino-U.S. CRO WuXi in Deal Worth $1.6B
  
• Merck & Co. Negotiates Co-Promotion Rights to Nycomed’s Oral COPD Therapy in Certain European Countries
  
• PPD Opens Vaccine Clinical Research Center in Taizhou, China
  
• Invida to Commercialize Three Ipsen Drugs in Asia Pacific Countries
  
• Kissei Pays Protox $3M Up Front to Develop Clinical-Stage Prostate Cancer Therapy in Japan
  
• Glycos Biotechnologies to Build Biochemical Plant and R&D Facility in Malaysia
  
• Merck Gains Control of Ariad’s Ridaforolimus Program
  
• GC-Rise and JS Bio Pharm Sign Separate Agreements for MediGene’s Genital Warts Treatment
  
• Abbott Steps Up Presence in Emerging Markets through Deal with Zydus
  
• Merck & Co. Inks Partnership with ElexoPharm Focused on Cardiovascular Diseases
  
• Abbott Boosts Presence in India with Acquisition of Generics Business for $3.72B
  
• Pfizer to Withdraw AML Drug Following Disappointing Postapproval Trial Results
  
• Trials Halted as Pfizer's Tanezumab Shown to Worsen Osteoarthritis
  
• Merck Teams with Adcock Ingram to Market OTC and Rx Products in South Africa